• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对健康个体循环游离 DNA 和血细胞中突变等位基因频率水平的统计分析。

Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.

机构信息

Department of Gastrointestinal Surgery, Shenzhen People's Hospital, the Second Clinical Medical College of Jinan University, Shenzhen, 518020, China.

Department of Biology, South University of Science and Technology of China, Shenzhen, 518055, China.

出版信息

Sci Rep. 2017 Aug 8;7(1):7526. doi: 10.1038/s41598-017-06106-1.

DOI:10.1038/s41598-017-06106-1
PMID:28790338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5548860/
Abstract

Cell-free DNA (cfDNA) in plasma has emerged as a potential important biomarker in clinical diagnostics, particularly in cancer. However, somatic mutations are also commonly found in healthy individuals, which interfere with the effectiveness for cancer diagnostics. This study examined the background somatic mutations in white blood cells (WBC) and cfDNA in healthy controls based on sequencing data from 821 non-cancer individuals and several cancer samples with the aim of understanding the patterns of mutations detected in cfDNA. We determined the mutation allele frequencies in both WBC and cfDNA using a panel of 50 cancer-associated genes that covers 20 K-nucleotide region and ultra-deep sequencing with average depth >40000-fold. Our results showed that most of the mutations in cfDNA were highly correlated to WBC. We also observed that the NPM1 gene was the most frequently mutated gene in both WBC and cfDNA. Our study highlighted the importance of sequencing both cfDNA and WBC to improve the sensitivity and accuracy for calling cancer-related mutations from circulating tumour DNA, and shedded light on developing a strategy for early cancer diagnosis by cfDNA sequencing.

摘要

血浆中的无细胞 DNA(cfDNA)已成为临床诊断中一种有潜力的重要生物标志物,特别是在癌症方面。然而,体细胞突变在健康个体中也很常见,这会干扰癌症诊断的效果。本研究基于 821 名非癌症个体和一些癌症样本的测序数据,检查了健康对照个体白细胞(WBC)和 cfDNA 中的背景体细胞突变,旨在了解 cfDNA 中检测到的突变模式。我们使用涵盖 20 K 核苷酸区域的 50 个与癌症相关的基因panel 以及平均深度 >40000 倍的超深度测序,来确定 WBC 和 cfDNA 中的突变等位基因频率。我们的结果表明,cfDNA 中的大多数突变与 WBC 高度相关。我们还观察到,NPM1 基因是 WBC 和 cfDNA 中突变最频繁的基因。我们的研究强调了同时对 cfDNA 和 WBC 进行测序的重要性,以提高从循环肿瘤 DNA 中调用癌症相关突变的灵敏度和准确性,并为通过 cfDNA 测序进行早期癌症诊断制定了策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/6f711c53f2c4/41598_2017_6106_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/22e002c9c019/41598_2017_6106_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/35f958386457/41598_2017_6106_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/9b94bfa5b831/41598_2017_6106_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/6f711c53f2c4/41598_2017_6106_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/22e002c9c019/41598_2017_6106_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/35f958386457/41598_2017_6106_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/9b94bfa5b831/41598_2017_6106_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c90/5548860/6f711c53f2c4/41598_2017_6106_Fig4_HTML.jpg

相似文献

1
Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.对健康个体循环游离 DNA 和血细胞中突变等位基因频率水平的统计分析。
Sci Rep. 2017 Aug 8;7(1):7526. doi: 10.1038/s41598-017-06106-1.
2
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.在基因组 DNA 中检测到的低频等位基因突变会影响下一代测序技术在游离 DNA 中的突变检测准确性。
Cancer. 2018 Mar 1;124(5):1061-1069. doi: 10.1002/cncr.31152. Epub 2017 Nov 27.
3
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.21807 例晚期癌症患者的游离循环肿瘤 DNA 中可操作基因组改变的全景分析。
Clin Cancer Res. 2018 Aug 1;24(15):3528-3538. doi: 10.1158/1078-0432.CCR-17-3837. Epub 2018 May 18.
4
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.高通量测序揭示了血浆游离循环 DNA 变异体的来源。
Nat Med. 2019 Dec;25(12):1928-1937. doi: 10.1038/s41591-019-0652-7. Epub 2019 Nov 25.
5
Characterization of DNA lesions associated with cell-free DNA by targeted deep sequencing.通过靶向深度测序对游离 DNA 相关的 DNA 损伤进行表征。
BMC Med Genomics. 2021 Jul 28;14(1):192. doi: 10.1186/s12920-021-01040-8.
6
Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients.Ⅱ-Ⅲ期可切除食管鳞癌患者循环游离 DNA 的靶向测序。
BMC Cancer. 2019 Aug 20;19(1):818. doi: 10.1186/s12885-019-6025-2.
7
Identification of driver genes and somatic mutations in cell-free DNA of patients with pulmonary lymphangioleiomyomatosis.鉴定肺淋巴管肌瘤病患者游离 DNA 中的驱动基因和体细胞突变。
Int J Cancer. 2020 Jan 1;146(1):103-114. doi: 10.1002/ijc.32511. Epub 2019 Jul 3.
8
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.在 MOSCATO 前瞻性试验中,采用下一代测序技术对 50 个基因的循环肿瘤游离 DNA 进行分析。
Clin Cancer Res. 2016 Jun 15;22(12):2960-8. doi: 10.1158/1078-0432.CCR-15-2470. Epub 2016 Jan 12.
9
High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.早期乳腺癌患者循环游离 DNA 中的高突变负担与不良无复发生存相关。
Cancer Med. 2020 Aug;9(16):5922-5931. doi: 10.1002/cam4.3258. Epub 2020 Jun 29.
10
Error-Corrected Deep Targeted Sequencing of Circulating Cell-Free DNA from Colorectal Cancer Patients for Sensitive Detection of Circulating Tumor DNA.用于灵敏检测循环肿瘤DNA的结直肠癌患者循环游离DNA的纠错深度靶向测序
Int J Mol Sci. 2024 Apr 11;25(8):4252. doi: 10.3390/ijms25084252.

引用本文的文献

1
Mining nucleic acid "omics" to boost liquid biopsy in cancer.挖掘核酸“组学”以推动癌症的液体活检。
Cell Rep Med. 2024 Sep 17;5(9):101736. doi: 10.1016/j.xcrm.2024.101736.
2
Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas.循环肿瘤DNA作为B细胞非霍奇金淋巴瘤CAR-T治疗期间的补充预后生物标志物
Cancers (Basel). 2024 May 15;16(10):1881. doi: 10.3390/cancers16101881.
3
Next-generation sequencing methodologies to detect low-frequency mutations: "Catch me if you can".

本文引用的文献

1
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.通过无标记平台捕获的循环肿瘤细胞中KRAS、BRAF和PIK3CA突变的计数及靶向分析:与转移性结直肠癌中的循环肿瘤DNA和组织的比较
Oncotarget. 2016 Dec 20;7(51):85349-85364. doi: 10.18632/oncotarget.13350.
2
Emerging technologies for salivaomics in cancer detection.癌症检测中唾液组学的新兴技术。
J Cell Mol Med. 2017 Apr;21(4):640-647. doi: 10.1111/jcmm.13007. Epub 2016 Nov 13.
3
ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy.
下一代测序方法检测低频突变:“若能抓住,尽管来抓”。
Mutat Res Rev Mutat Res. 2023 Jul-Dec;792:108471. doi: 10.1016/j.mrrev.2023.108471. Epub 2023 Sep 15.
4
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience.建立液体活检方法检测循环肿瘤DNA中驱动突变的陷阱与回报:我们机构的经验
J Pers Med. 2022 Nov 4;12(11):1845. doi: 10.3390/jpm12111845.
5
A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer.循环肿瘤 DNA 在食管癌诊断和监测中的研究进展。
Med Sci Monit. 2022 Feb 25;28:e934106. doi: 10.12659/MSM.934106.
6
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesis.食管癌的液体活检:一例因克隆性造血导致循环肿瘤DNA检测假阳性的病例报告
Ann Transl Med. 2021 Aug;9(15):1264. doi: 10.21037/atm-21-525.
7
Clinical implementation and current advancement of blood liquid biopsy in cancer.液体活检在癌症中的临床应用及最新进展。
J Hum Genet. 2021 Sep;66(9):909-926. doi: 10.1038/s10038-021-00939-5. Epub 2021 Jun 4.
8
Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment.循环肿瘤 DNA 突变作为一种液体活检在肺癌检测和治疗中的应用。
Mol Oncol. 2021 Jun;15(6):1667-1682. doi: 10.1002/1878-0261.12983. Epub 2021 May 26.
9
Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma.肽亲和沉淀法提取细胞外囊泡和游离 DNA 可提高肺癌患者血浆中致病突变检测的测序性能。
Int J Mol Sci. 2020 Nov 29;21(23):9083. doi: 10.3390/ijms21239083.
10
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications.液体活检中的克隆性造血:从生物噪声到有价值的临床意义。
Cancers (Basel). 2020 Aug 14;12(8):2277. doi: 10.3390/cancers12082277.
循环肿瘤DNA动态变化:一种用于追踪抗HER2治疗转移性乳腺癌耐药性的新型指标。
Oncotarget. 2016 Oct 4;7(40):66020-66031. doi: 10.18632/oncotarget.11791.
4
Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.游离DNA(cfDNA):新兴技术塑造的癌症临床意义及应用
Mol Cancer Res. 2016 Oct;14(10):898-908. doi: 10.1158/1541-7786.MCR-16-0044. Epub 2016 Jul 15.
5
Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.非小细胞肺癌从早期到晚期进展的时间:SEER 登记处和单个机构数据的分析。
Sci Rep. 2016 Jun 27;6:28477. doi: 10.1038/srep28477.
6
Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease.肺癌:利用循环肿瘤DNA追踪晚期疾病中的表皮生长因子受体和 Kirsten 大鼠肉瘤病毒癌基因同源物突变
Nat Rev Clin Oncol. 2016 Jul;13(7):401-2. doi: 10.1038/nrclinonc.2016.83. Epub 2016 Jun 1.
7
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.560例乳腺癌全基因组序列中的体细胞突变图谱。
Nature. 2016 Jun 2;534(7605):47-54. doi: 10.1038/nature17676. Epub 2016 May 2.
8
Integrated digital error suppression for improved detection of circulating tumor DNA.用于改善循环肿瘤DNA检测的集成数字误差抑制
Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.
9
Extensive Variation in the Mutation Rate Between and Within Human Genes Associated with Mendelian Disease.与孟德尔疾病相关的人类基因之间及内部突变率的广泛差异。
Hum Mutat. 2016 May;37(5):488-94. doi: 10.1002/humu.22967. Epub 2016 Mar 14.
10
Cancer genomics: A nucleosome footprint reveals the source of cfDNA.癌症基因组学:一个核小体足迹揭示了游离DNA的来源。
Nat Rev Genet. 2016 Mar;17(3):125. doi: 10.1038/nrg.2016.3. Epub 2016 Jan 25.